Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II begins for irofulven + irinotecan in advanced gastrointestinal solid tumors

July 18, 2002

Procyon and Chiron extend PSP94 technology option agreement

July 18, 2002

Telik exercises option to develop compounds from Arizona Cancer Center collaboration

July 17, 2002

Fumagillin derivatives and their use in angiogenesis disorders

July 17, 2002

Aromasin approved in Japan for postmenopausal breast cancer

July 16, 2002

GenVec and DirectGene collaborate to develop targeted cancer therapies

July 16, 2002

Alimta expanded access program cleared for malignant pleural mesothelioma

July 16, 2002

Capecitabine + docetaxel improves survival in advanced breast cancer

July 16, 2002

Actimid shows antitumor activity in multiple myeloma

July 15, 2002

Enzon to reacquire Oncaspar rights from Aventis

July 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...